Page last updated: 2024-12-08

deoxynyboquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

deoxynyboquinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID295934
CHEMBL ID1972926
SCHEMBL ID14873825
MeSH IDM0547925

Synonyms (19)

Synonym
8-hydroxy-1,4,6-trimethylpyrido[3,2-g]quinoline-2,5,10(1h)-trione
{pyrido[3,2-g]quinoline-2,5,8,10(1h,9h)-tetrone,} 1,4,6-trimethyl-
8-hydroxy-1,4,6-trimethyl-pyrido[3,2-g]quinoline-2,5,10-trione
pyrido[3,5,8,10(1h,9h)-tetrone, 1,4,6-trimethyl-
nsc165572
nsc-165572
NCI60_001271
1,4,6-trimethyl-9h-pyrido[3,2-g]quinoline-2,5,8,10-tetrone
SCHEMBL14873825
CHEMBL1972926
deoxynyboquinone
96748-86-6
AKOS027324995
1,4,6-trimethylpyrido[3,2-g]quinoline-2,5,8,10(1h,9h)-tetrone
MS-24042
1,4,6-trimethylpyrido[3,2-g]quinoline-2,5,8,10(1h,9h)-tetraone
deoxynyboqionone
HY-108992
CS-0033907

Research Excerpts

Overview

Deoxynyboquinone (DNQ) is a potent antineoplastic agent with an unknown mechanism of action.

ExcerptReferenceRelevance
"Deoxynyboquinone (DNQ) is a potent antineoplastic agent with an unknown mechanism of action. "( Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death.
Bair, JS; Hergenrother, PJ; Palchaudhuri, R, 2010
)
2.11
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1617942Antibacterial activity against Bacillus subtilis ATCC 6633 after 16 to 48 hrs2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
AID1617944Antibacterial activity against Escherichia coli ATCC 12435 after 16 to 48 hrs2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
AID1617947Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by alamar blue assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
AID1617941Antibacterial activity against Micrococcus luteus ATCC 15307 after 16 to 48 hrs2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
AID1617940Antibacterial activity against Staphylococcus aureus ATCC 6538 after 16 to 48 hrs2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
AID1617945Antibacterial activity against Salmonella enterica ATCC 10708 after 16 to 48 hrs2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
AID1617943Antibacterial activity against Mycobacterium aurum ATCC 23366 after 16 to 48 hrs2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
AID1424115Antibacterial activity against Bacillus thuringiensis SCSIO BT012017Journal of natural products, 04-28, Volume: 80, Issue:4
Antibacterial Compounds from Marine Bacteria, 2010-2015.
AID1424144Antibacterial activity against Enterococcus faecalis ATCC 292122017Journal of natural products, 04-28, Volume: 80, Issue:4
Antibacterial Compounds from Marine Bacteria, 2010-2015.
AID1617946Antifungal activity against Saccharomyces cerevisiae ATCC 204508 after 16 to 48 hrs2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
AID1424102Antibacterial activity against Staphylococcus aureus ATCC 292132017Journal of natural products, 04-28, Volume: 80, Issue:4
Antibacterial Compounds from Marine Bacteria, 2010-2015.
AID1617948Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by alamar blue assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
AID1617951Inhibition of 4E-BP1 phosphorylation in human HCT116 cells at 1 uM after 6 hrs by Western blot analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.41 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.53 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]